The Evolution of Viral Patient Advocacy in Rare Disease Care
The traditional path to accessing life-saving medicine often involves a grueling climb through bureaucratic layers, insurance approvals, and medical red tape. However, a shifting trend is emerging where patients and families are bypassing these traditional channels by leveraging the power of social media to create immediate, high-visibility pressure.
A poignant example of this trend is seen in the case of Will Roberts, a 15-year-old from Tuscaloosa County battling stage four osteosarcoma. After finding that traditional efforts to secure a specific drug were moving slowly, Will took matters into his own hands. By posting a nearly three-minute video to Facebook, he achieved in hours what his parents had attempted for a week.
Leveraging High-Profile Intermediaries for Medical Access
One of the most significant trends in modern healthcare advocacy is the strategic targeting of public figures to accelerate medical interventions. Rather than relying solely on medical boards, families are now appealing directly to policymakers and public personalities who have the influence to reach drug developers or government heads.

In Will’s case, the viral strategy specifically aimed for the attention of President Donald Trump and United States Secretary of Health and Human Services Robert F. Kennedy, Jr. The effectiveness of this approach was validated when the video reached U.S. Senators Katie Britt and Tommy Tuberville, and prompted Dr. Mehmet Oz to personally reach out to the developers of the medicine.
This suggests a future where “social capital” becomes a critical component of patient care, where the ability to garner public attention can potentially shorten the time between the discovery of a treatment and its administration.
The Challenge of Specialized Care Geography
As medicine becomes more specialized, a growing gap is appearing between where a patient lives and where the most advanced treatments are available. This creates a logistical and financial burden that often accompanies the medical struggle.
For the Roberts family, the potential treatment for Will’s rare and aggressive bone cancer requires a three-week stay in California. This highlights a recurring theme in rare disease treatment: the necessity of medical travel. For families balancing full-time jobs, the requirement to relocate—even temporarily—to a different state for care adds a layer of complexity to an already devastating situation.
Navigating the Emotional Cycle of Recurrence
The psychological toll of rare cancer is often compounded by the “false start”—the moment a patient is told they are cancer-free, only to face a recurrence. Will Roberts described the frustration of “ringing the bell” and being told he was cancer-free, only for subsequent scans to show the disease had spread again.

This emotional volatility is a key aspect of the patient experience in stage four osteosarcoma. The trend in patient support is moving toward a more holistic approach that recognizes this frustration, emphasizing a refusal to be “defined by” the disease and focusing on enjoying every single day as a gift.
Frequently Asked Questions
Osteosarcoma is a rare and aggressive form of bone cancer. In the case of Will Roberts, he is battling stage four of this disease, which can impact a patient’s ability to engage in activities like sports, hunting, and fishing.
How can social media help in medical cases?
Social media can be used to raise awareness, gather community support, and bring a patient’s story to the attention of high-profile individuals, such as government officials or medical experts, who may have the influence to facilitate access to experimental or restricted drugs.
What are the barriers to accessing specialized medicine?
Barriers include bureaucratic delays in Washington, D.C., the difficulty of reaching drug developers, and the logistical challenges of traveling to specific treatment centers, such as those located in California.
Join the Conversation: Do you believe social media is becoming a necessary tool for patients to receive life-saving care? Share your thoughts in the comments below or subscribe to our newsletter for more updates on patient advocacy and medical breakthroughs.
